Clinical Trial

Predictive Value of Frailty Scores and Admission Laboratory Markers for Postoperative ICU Mortality

Study acronym: GERI-MORTAL
Completed
View on ClinicalTrials.gov →
Summary
This prospective observational study aims to evaluate the predictive value of the Clinical Frailty Scale (CFS), the Katz Activities of Daily Living (ADL) scale, and admission laboratory markers for postoperative mortality among geriatric patients admitted to the intensive care unit (ICU) after surgery. Frailty assessment and functional status are increasingly recognized as determinants of outcomes in older adults, yet their combined predictive power with routine laboratory parameters at ICU admission remains unclear. By systematically collecting clinical scores and laboratory data at the time of ICU admission, this study seeks to identify early predictors of mortality and support risk-stratification in geriatric postoperative patients.
Protocol Amendment History 1 amendment
This ClinicalTrials.gov record has been amended once since 2025-12-09.
Status change: Not Yet Recruiting → Completed 2026-05-29
Trial Details
NCT Number NCT07279519
Lead Sponsor Malatya Egitim Ve Arastirma Hastanesi
Conditions Postoperative Mortality, Frailty at Older Adults, Activities of Daily Living, Postoperative Complications
Enrollment 393 participants
Start Date 2025-09-01
Primary Completion 2026-04-01 (estimated)
Study Completion 2026-04-15 (estimated)
Updated on ClinicalTrials.gov 2026-06-01